Latest Breaking News On - Head of research development japan - Page 1 : vimarsana.com

/PRNewswire/ Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced the following changes to its management.

City ofUnited kingdomKenji yasukawaHideki shimaNaoki okamuraCatherine levittFumiaki sakuraiBristol myers squibbYoshitsugu shitakaBernhardt zeiherKatsuyoshi sugitaYukio matsuiMinoru kikuokaTadaaki taniguchiAsahi kasei corpInfectious disease center hospital